Just Healthcare

Just Healthcare

Share this post

Just Healthcare
Just Healthcare
Slow Tapering of Semaglutide Maintains Weight Loss: New Study Insights
Copy link
Facebook
Email
Notes
More

Slow Tapering of Semaglutide Maintains Weight Loss: New Study Insights

Personalized Dosing and Digital Programs Key to Long-Term Success

Naveen Sankar S's avatar
Naveen Sankar S
May 15, 2024
∙ Paid

Share this post

Just Healthcare
Just Healthcare
Slow Tapering of Semaglutide Maintains Weight Loss: New Study Insights
Copy link
Facebook
Email
Notes
More
Share
A digital health themed image depicting a modern medical research setting. The scene includes a digital weight loss clinic with advanced technology interfaces and monitors displaying weight loss statistics. A diverse group of healthcare professionals, including doctors and health coaches, are interacting with patients who are using digital tablets. The clinic is sleek and futuristic, reflecting a high-tech approach to weight loss management. Emphasize a sense of innovation and personal care in the clinic's design.

Topline: A recent study highlights the effectiveness of personalized dosing and gradual tapering of semaglutide (Wegovy or Ozempic) in conjunction with a digital weight loss program. This approach achieves significant weight loss and maintains it for up to six months, offering promising implications for both patients and healthcare providers.

Study Detai…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More